XML 63 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Research and development expenses (Tables)
12 Months Ended
Dec. 31, 2025
Disclosure Of Detailed Information Research And Development Expenses [Abstract]  
Schedule of Breakdown of Research and Development Expenses

 

 

2025

 

 

2024

 

 

2023

 

 

 

 

 

 

 

 

Clinical expenses

 

 

(67,744,537

)

 

 

(55,867,694

)

 

 

(30,690,293

)

Personnel expenses (Note 5)

 

 

(35,755,155

)

 

 

(27,767,184

)

 

 

(19,132,307

)

Manufacturing costs

 

 

(12,024,982

)

 

 

(9,434,537

)

 

 

(6,500,986

)

Nonclinical expenses

 

 

(7,485,648

)

 

 

(3,324,513

)

 

 

(8,977,187

)

License costs

 

 

(1,065,471

)

 

 

(1,592,687

)

 

 

 

Intellectual Property costs

 

 

(402,541

)

 

 

(576,914

)

 

 

(274,257

)

 

 

(124,478,334

)

 

 

(98,563,529

)

 

 

(65,575,030

)